Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Martin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2008
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetesDavid A D'Alessio, Amanda M Denney, Linda M Hermiller, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|December 17, 2005
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexRaman Kumar, Paul M Neilsen, Joanne Crawford, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2008
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetesDavid A D'Alessio, Amanda M Denney, Linda M Hermiller, et al.
Cancer Research|August 17, 2002
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Marina Kochetkova, Olivia L D McKenzie, Anthony J Bais, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Pageof 2